Frontiers | Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | Haematologica
Abstract - 2020 - American Journal of Hematology - Wiley Online Library
Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data - Clinical Lymphoma, Myeloma and Leukemia
ICD-10 Code for Multiple myeloma- C90.0- Codify by AAPC
Neuropathy associated with IgA monoclonal Gammopathy. A harbinger of AL amyloidosis - Journal of the Neurological Sciences
Vol 80. Num 3 - Galicia Clínica
Multiple myeloma - Wikiwand
OAB-001 Potentiating T cell activity against multiple myeloma through SUMOylation inhibition Li Du1, Dennis Awuah1, Wei Liu2, En
Biomolecules | Free Full-Text | Anti-BCMA Immunotoxins: Design, Production, and Preclinical Evaluation | HTML
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
PDF) Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
Types of Multiple Myeloma | International Myeloma Foundation
ICD-10 International statistical classification of diseases and related health problems
Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | Haematologica
Part 2e. Instruction Manual- ICD-10-Volume 3
A phase I study of anti‐BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia - Li - 2021 - Clinical and Translational Medicine - Wiley Online Library